Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

导出原文传递

翻译打印收藏纠错

第一作者： M A,Pfaller

第一单位： JMI Laboratories, North Liberty, Iowa; University of Iowa, Iowa City, Iowa.

作者： M A,Pfaller ^[1] ; H S,Sader ^[2] ; R K,Flamm ^[2] ; M,Castanheira ^[2] ; Rodrigo E,Mendes ^[3]

作者单位： JMI Laboratories, North Liberty, Iowa; University of Iowa, Iowa City, Iowa. ^[1] JMI Laboratories, North Liberty, Iowa. ^[2] JMI Laboratories, North Liberty, Iowa. Electronic address: rodrigo-mendes@jmilabs.com. ^[3]

关键词 Gram-positive cocci Lipoglycopeptide Oritavancin

主题词抗菌药(Anti-Bacterial Agents);抗药性, 细菌(Drug Resistance, Bacterial);欧洲(Europe);糖肽类(Glycopeptides);革兰氏阳性菌(Gram-Positive Bacteria);革兰氏阳性菌感染(Gram-Positive Bacterial Infections);医院(Hospitals);人类(Humans);微生物敏感性试验(Microbial Sensitivity Tests);美国(United States)

DOI 10.1016/j.diagmicrobio.2018.01.029

PMID 29567128

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览17

Diagnostic microbiology and infectious disease

2018年91卷2期

199-204页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

Diagnostic microbiology and infectious disease

相似文献

Diagnostic microbiology and infectious disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

Diagnostic microbiology and infectious disease

相似文献

Diagnostic microbiology and infectious disease

相关期刊

检索历史清除